ES8403891A1 - Un procedimiento para la preparacion de un derivado del acido furiloxazolila-cetico - Google Patents

Un procedimiento para la preparacion de un derivado del acido furiloxazolila-cetico

Info

Publication number
ES8403891A1
ES8403891A1 ES520136A ES520136A ES8403891A1 ES 8403891 A1 ES8403891 A1 ES 8403891A1 ES 520136 A ES520136 A ES 520136A ES 520136 A ES520136 A ES 520136A ES 8403891 A1 ES8403891 A1 ES 8403891A1
Authority
ES
Spain
Prior art keywords
same
pharmaceutical compositions
carbon atoms
compositions containing
acid derivatives
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
ES520136A
Other languages
English (en)
Other versions
ES520136A0 (es
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Tanabe Seiyaku Co Ltd
Original Assignee
Tanabe Seiyaku Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Tanabe Seiyaku Co Ltd filed Critical Tanabe Seiyaku Co Ltd
Publication of ES8403891A1 publication Critical patent/ES8403891A1/es
Publication of ES520136A0 publication Critical patent/ES520136A0/es
Granted legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D413/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/04Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/06Antihyperlipidemics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D307/00Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/02Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings
    • C07D307/34Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D307/38Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D307/52Radicals substituted by nitrogen atoms not forming part of a nitro radical
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D307/00Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/02Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings
    • C07D307/34Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D307/38Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D307/54Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Diabetes (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Hematology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • Obesity (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Cephalosporin Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)

Abstract

PROCEDIMIENTO PARA LA PREPARACION DE UN DERIVADO DEL ACIDO FURILOXAZOLILACETICO, DE FORMULA GENERAL (I), EN LA QUE R1 ES ALQUILO DE 1 A 6 ATOMOS DE CARBONO, FENILO O FENILO SUSTITUIDO; Y R2 ES HIDROGENO O ALQUILO DE 1 A 12 ATOMOS DE CARBONO.CONSISTE EN SOMETER A UNA REACCION DE CICLACION DESHIDRATANTE, UN COMPUESTO DE FORMULA GENERAL (II), EN LA QUE R1 TIENE EL SIGNIFICADO YA INDICADO; Y R3 ES ALQUILO DE 1 A 12 ATOMOS DE CARBONO. OPCIONALMENTE SE HIDROLIZA EL COMPUESTO OBTENIDO PARA PRODUCIR EL COMPUESTO DESEADO, EN EL QUE R2 ES HIDROGENO.DE APLICACION COMO AGENTE HIPOLIPIDEMICOEN COMPOSICIONES FARMACEUTICAS.
ES520136A 1982-02-26 1983-02-25 Un procedimiento para la preparacion de un derivado del acido furiloxazolila-cetico Granted ES520136A0 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP57030921A JPS58148882A (ja) 1982-02-26 1982-02-26 フリルオキサゾリル酢酸誘導体及びその製法

Publications (2)

Publication Number Publication Date
ES8403891A1 true ES8403891A1 (es) 1984-04-01
ES520136A0 ES520136A0 (es) 1984-04-01

Family

ID=12317149

Family Applications (1)

Application Number Title Priority Date Filing Date
ES520136A Granted ES520136A0 (es) 1982-02-26 1983-02-25 Un procedimiento para la preparacion de un derivado del acido furiloxazolila-cetico

Country Status (14)

Country Link
US (1) US4642313A (es)
EP (1) EP0087782B1 (es)
JP (1) JPS58148882A (es)
KR (1) KR900001423B1 (es)
AT (1) ATE19879T1 (es)
BG (1) BG39977A3 (es)
CA (1) CA1194483A (es)
DE (1) DE3363575D1 (es)
DK (1) DK82583A (es)
ES (1) ES520136A0 (es)
HK (1) HK87188A (es)
HU (1) HU193648B (es)
SG (1) SG10688G (es)
SU (1) SU1169536A3 (es)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS59152382A (ja) * 1983-02-18 1984-08-31 Tanabe Seiyaku Co Ltd フリルオキサゾリル酢酸誘導体
US7071174B1 (en) 1994-10-13 2006-07-04 Cv Therapeutics, Inc. Method and composition for inhibiting cholesterol esterase
AU682792B2 (en) * 1994-10-13 1997-10-16 Cv Therapeutics, Inc. Method of manufacturing non-absorbable synthetic sulfated polysaccharides
NZ529043A (en) * 2001-04-16 2006-11-30 Tanabe Seiyaku Co Large conductance calcium-activated K channel opener

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IE32084B1 (en) * 1967-06-07 1973-04-04 Wyeth John & Brother Ltd Thiazole derivatives
FI53314C (fi) * 1967-06-14 1978-04-10 Wyeth John & Brother Ltd Foerfarande foer framstaellning av farmaceutiskt anvaendbar 2-(fenyleller p-klorfenyl) oxazol-4-yl (aettiksyra -acetatsalt eller -acetamid)
GB1245087A (en) * 1967-10-26 1971-09-02 Wyeth John & Brother Ltd Heterocyclic compounds
US3578671A (en) * 1967-11-06 1971-05-11 Wyeth John & Brother Ltd Oxazoles
FR2068418A1 (en) * 1969-10-27 1971-08-27 Innothera Lab Sa 2-substd-5-amino isoxazole derivs
AR208400A1 (es) * 1974-03-13 1976-12-27 Yoshitomi Pharmaceutical Un metodo para producir nuevos acidos 5-alcoxi-4-oxazolalcanoicos 2-substituidos y sus esteres
JPS51110039A (ja) * 1975-02-28 1976-09-29 Yoshitomi Pharmaceutical Ketsuchushishitsutaishakaizenzai
GB1542315A (en) * 1976-08-13 1979-03-14 Wyeth John & Brother Ltd Process for preparing oxazoles
JPS5677268A (en) * 1979-11-28 1981-06-25 Yoshitomi Pharmaceut Ind Ltd Oxazoleacetic acid derivative
JPS57188587A (en) * 1981-05-15 1982-11-19 Tanabe Seiyaku Co Ltd Thienyloxazolylacetic acid derivative and its preparation

Also Published As

Publication number Publication date
SU1169536A3 (ru) 1985-07-23
SG10688G (en) 1988-07-01
EP0087782A1 (en) 1983-09-07
BG39977A3 (en) 1986-09-15
ATE19879T1 (de) 1986-06-15
KR840003632A (ko) 1984-09-15
DK82583A (da) 1983-08-27
ES520136A0 (es) 1984-04-01
CA1194483A (en) 1985-10-01
DK82583D0 (da) 1983-02-23
EP0087782B1 (en) 1986-05-21
DE3363575D1 (en) 1986-06-26
KR900001423B1 (ko) 1990-03-09
JPS58148882A (ja) 1983-09-05
HU193648B (en) 1987-11-30
JPS635027B2 (es) 1988-02-01
HK87188A (en) 1988-11-04
US4642313A (en) 1987-02-10

Similar Documents

Publication Publication Date Title
ES8406426A1 (es) Metodo de preparar derivados sulfonato.
CA2036876A1 (fr) Derives a structure naphtalenique, leur procede de preparation et les compositions pharmaceutiques qui les contiennent
ZA83328B (en) 5,6,7-trinor-4,8-itner-m-phenylene prostaglandin i2 derivative
PT77410B (en) Process for the preparation of a fungicidal composition containing substituted 1-hydroxymethyltriazolyl derivatives
ES8706664A1 (es) Procedimiento para preparar compuestos carbostirilicos
AU548974B2 (en) Oligoglucoside derivatives
ES8503667A1 (es) Un procedimiento para la preparacion de nuevos derivados de 2-oxo-imidazolina.
ES8505518A1 (es) Procedimiento para preparar derivados de aminoacidos
ES8101550A1 (es) Un procedimiento para la preparacion de nuevos derivados de 2-pirrolidin-metanol.
DE3266708D1 (en) Pyridazinone derivatives, process for their preparation and their use as fungicides
ES8106289A1 (es) Procedimiento de preparacion de nuevos derivados del a-fe- nil-2-pirrolidin-metanol
ES8203870A1 (es) Procedimiento para preparar difenilbutil-1-acilpiperazinas
ES8403891A1 (es) Un procedimiento para la preparacion de un derivado del acido furiloxazolila-cetico
GB2017087A (en) Process for the preparation of xanthone derivatives
DE3174132D1 (en) New ethenylimidazole derivatives, processes for their preparation and pharmaceutical compositions containing them; intermediates, useful in their preparation and a process for the preparation thereof
ES8801637A1 (es) Un procedimiento para la preparacion de benzimidazoles.
ES8400743A1 (es) "procedimiento para la preparacion de compuestos de 1-fenilindazol-3-ona".
BR8603787A (pt) Compostos heterociclicos,e,processo de sua preparacao e aplicacao
ES8407482A1 (es) Un procedimiento para la preparacion de nuevos derivados de acidos alquiloxazolilaceticos.
GB2111056A (en) Derivatives of 1, 4-thiazane-carboxylic acid preparation and utilization thereof and compositions containing same
HUT39158A (en) Process for preparing carbacyclines and pharmaceutical compositions containing such compounds
ES8401957A1 (es) Procedimiento de preparacion de derivados del acido 2-tiofen-acetico.
ES8506702A1 (es) Un derivado del acido furiloxazolilacetico
ES485801A1 (es) Un procedimiento de preparacion de ciclo-1,3,2-oxazafosfo- ril-derivados
AU551839B2 (en) Imidazolylcarboxylic acids and derivative

Legal Events

Date Code Title Description
FD1A Patent lapsed

Effective date: 19991108